Furthermore, in ovarian cancer, WWOX influences the cell cycle of ovarian cancer stem cells and inhibits their proliferation by downregulating the expression levels of cyclins, specifically cyclin E-CDK2 and cyclin D1-CDK4 [66]. Here, CDK2 is linked to ovarian carcinoma.